Check our latest Perspective’s blog by Matthew Hoover. Explore the transformative power of immuno-oncology therapies targeting CTLA-4, PD-1, and PD-L1, enhancing the immune system’s ability to fight tumors. While offering new hope, these treatments also present unique challenges, including immune-related adverse events (irAEs) that mirror autoimmune disorders and can impact any organ system. Early detection and management of irAEs are vital for patient outcomes. This blog delves into traditional and innovative methods for identifying irAEs, from clinical observation to advanced molecular imaging, ensuring optimized treatment and patient care. Read here: https://lnkd.in/gQgP4X99 #ImmunoOncology #CancerTreatment #irAEs #InnovationInHealthcare #CD8ImmunoPET #immunooncology #immunotherapy
ImaginAb’s Post
More Relevant Posts
-
Learn how researchers at Adaptimmune leveraged Ultivue’s completely customizable OmniVUE™ panels to visualize and quantify the immune response to an engineered TCR T-cell therapy in a clinical trial. This clip highlights data obtained on the adaptive and innate immune response from tissue biopsies post-treatment. For instance, researchers were able to show an increase in the ratio between M1 and M2 macrophages post-infusion, indicating a strong innate anti-tumor response and how the M2/cytotoxic T-cell ratio was markedly different in partial responding and non-responding patient samples. Watch our webinar to hear more about the use of Ultivue’s InSituPlex® technology in Adaptimmune’s clinical trial: https://hubs.ly/Q02N61Fx0 #SpatialBiology #Multiplex #mIF #ImmuneProfiling #ImmunoOncology #ImageAnalysis #TumorMicroenvironment #Biomarkers #BiomarkerDiscovery #InSituPlex #OmniVUE
To view or add a comment, sign in
-
A nationwide cohort study in Taiwan investigated the impact of adjunctive Chinese medicine therapy on non-small cell lung cancer patients. The findings suggested that receiving Chinese medicine alongside conventional treatments, particularly for 181-365 days, reduced the mortality risk among stage IV patients. Cost-effectiveness analysis showed positive results aligning with economic benefits. #ChineseMedicine #NSCLC #CancerTreatment #SurvivalOutcomes #CostEffectiveness Read more here: https://lnkd.in/eSJSBEBy BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X.
To view or add a comment, sign in
-
Cutting-edge technologies like at-home amyloid tests, minimally-invasive blood assays, and circulating tumor DNA tests are revolutionizing personalized health care—enabling earlier detection of diseases like Alzheimer’s and cancer, and tailoring treatments to individual patients. Download the free e-book from STAT to uncover the technological breakthroughs shaping the future of health care, from innovative liquid biopsies to functional precision medicine, and how these advancements are accelerating the fight against some of the world’s most complex diseases. https://bit.ly/3zLUBHX #PrecisionMedicine #GeneticSequencing #CancerResearch #AlzheimersResearch
To view or add a comment, sign in
-
Are you attending #NordicPMF? Are you interested in the potential for liquid biopsy? So are we! We are thrilled to be joined by Professor Giancarlo Pruneri who will be sharing his experiences and talking about the value he sees for liquid biopsy in diagnostic setting. #NordicPMF #Precisionmedicineforum Precision Medicine Forum
To view or add a comment, sign in
-
Are you attending #NordicPMF? Are you interested in the potential for liquid biopsy? So are we! We are thrilled to be joined by Professor Giancarlo Pruneri who will be sharing his experiences and talking about the value he sees for liquid biopsy in diagnostic setting. #NordicPMF #Precisionmedicineforum Precision Medicine Forum
Nordic Precision Medicine Forum - Precision Oncology Forum 2024
emea.illumina.com
To view or add a comment, sign in
-
Are you attending #NordicPMF? Are you interested in the potential for liquid biopsy? So are we! We are thrilled to be joined by Professor Giancarlo Pruneri who will be sharing his experiences and talking about the value he sees for liquid biopsy in diagnostic setting. #NordicPMF #Precisionmedicineforum Precision Medicine Forum
Nordic Precision Medicine Forum - Precision Oncology Forum 2024
emea.illumina.com
To view or add a comment, sign in
-
Increased awareness! Ealier ct scans! --> Correct and ealier diagnosis --> Better prognosis, less costs
✔ The Survey of Challenges in Access to Diagnostics and Treatment for NET Patients (#SCAN), which measured access to diagnostics, treatments and monitoring for neuroendocrine tumor (NET) patients globally, identified poor patient awareness of diagnostics, treatments and clinical trials, likely due to poor access to NET information. Patients believed GPs lacked NET knowledge and struggled to obtain information from healthcare professionals not specialized in NETs. ☑ Check out more insights on “Global Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients” in the INCA review article, published in the Journal of Neuroendocrinology with open access: https://lnkd.in/eQJk_4bw #LetsTalkAboutNETs #NeuroendocrineCancer #NETResearch
To view or add a comment, sign in
-
Research shows that patients and providers can learn more from DNA found in a blood sample. Learn more by reading our latest article. Director of the Vanderbilt University Medical Center, Dr. Ben Ho Park explains the potential discoveries of circulating tumor DNA from a simple blood draw, as well as the possible disadvantages. Read Now: https://ow.ly/30YR50Uk5He
To view or add a comment, sign in
-
Evaluating Mitochondrial Dysfunction: Metabolic Analysis & Respirometry Naïg Gueguen, CHU d'Angers, explored this topic, highlighting the role of mitochondrial dysfunction in metabolic, vascular, cardiac, neurodegenerative diseases, and cancer. Respirometry, once limited to specialized labs, is now more accessible thanks to advancements in technology. The Seahorse® automated plate reader enables high-throughput analysis by measuring oxygen consumption and proton extrusion rates, while the latest Oroboros® high-resolution oxygraphs allow parallel assessment of respiration rates, mitochondrial membrane potential, and ROS production. Dr. Gueguen also discussed complementary clinical markers for initial evaluations of mitochondrial dysfunction. #WorldMitochondriaSociety #TargetingMitochondria2024 #mitochondria #mitochondrialdysfunction #respirometry #metabolicanalysis
To view or add a comment, sign in
-
Unleash the potential of #liquidbiopsy with Caris Assure, an innovative multi-cancer assay that provides deep molecular insights from a simple blood sample. Explore how this powerful liquid biopsy assay can revolutionize patient care. Learn more: https://lnkd.in/gmgXniEd
To view or add a comment, sign in
6,034 followers
Chief Commercial Officer at RadMD, a Medica Company
3moCongrats Matthew Hoover on this article!